| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1fd34fea6801ea1d9286475b96be2d26 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-61
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-09 |
| filingDate |
2000-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c7f21d2ef7428b658187af89c2bdc9be
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_18bada4f172465e97db5b4399ee0bda1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0efbc0c482938da7b350c2fa5d085415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_184b635eeb2dce8df1214f4e9da27dc1 |
| publicationDate |
2000-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-0047234-A1 |
| titleOfInvention |
Sustained release salts of pharmaceutically active peptides and their production |
| abstract |
Substained delivery pharmaceutical compositions comprise a water insoluble salt of a pharmaceutically active ionic peptide and a counterionic carrier macromolecule. The peptide may be an LHRH antagonist such as cetrorelix and the macromolecule may be an anionic polysaccharide such as carboxymethylcellulose. The salt is prepared using ion exchangers to sepArately remove the counterions from the peptide and the carrier macromolecule thereby forming free peptide/macromolecule ions. These free peptide and macromolecule ions are then combined to form the water insoluble peptide-macromolecule salt. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7906479-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010095533-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7282480-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006069641-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7871977-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7098305-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2198888-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-012183-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8415300-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013177449-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100452752-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-100386116-C
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1674082-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7214662-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/HR-P20050371-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03022243-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03022243-A2 |
| priorityDate |
1999-02-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |